PP
MYOV

PDT Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

PDT Partners’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-43,464
Closed -$226K – 780
2019
Q3 		$226K Buy
+43,464
New +$322K 0.01% 401

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PDT Partners's MYOV Position: Q4 2019 in Review

PDT Partners sold out of Myovant Sciences Ltd. (MYOV) in Q4 2019, closing a stake of 43,464 shares — an estimated $226K sold.

PDT Partners first reported a position in MYOV in Q3 2019 and held it in 1 quarter. The position peaked at $226K in Q3 2019. 77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

  • PDT Partners reported no remaining Myovant Sciences Ltd. position as of Q4 2019 after selling out during the quarter.
  • PDT Partners sold 43,464 Myovant Sciences Ltd. shares in Q4 2019, an estimated $226K.
  • PDT Partners first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 1 quarter.
  • PDT Partners's Myovant Sciences Ltd. position peaked at $226K in Q3 2019.
  • 77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on PDT Partners's 13F filing for Q4 2019, filed 14 Feb 2020.